Ticker	Volume	Price	Price Delta
DJIA	12,454.80	-74.92	-0.60%
S&P 500	1,317.82	-2.86	-0.22%
Nasdaq	2,837.53	-1.85	-0.07%

Ticker

Volume

Price

Price Delta

DJIA

12,454.80

-74.92

-0.60%

S&P 500

1,317.82

-2.86

-0.22%

Nasdaq

2,837.53

-1.85

-0.07%

Ticker	Volume	Price	Price Delta
STOXX 50	2,151.86	+3.94	0.18%
FTSE 100	5,370.09	+13.75	0.26%
DAX	6,376.01	+52.82	0.84%

Ticker

Volume

Price

Price Delta

STOXX 50

2,151.86

+3.94

0.18%

FTSE 100

5,370.09

+13.75

0.26%

DAX

6,376.01

+52.82

0.84%

Ticker	Volume	Price	Price Delta
Nikkei	8,657.08	+63.93	0.74%
TOPIX	727.03	+5.92	0.82%
Hang Seng	19,055.50	+254.47	1.35%

Ticker

Volume

Price

Price Delta

Nikkei

8,657.08

+63.93

0.74%

TOPIX

727.03

+5.92

0.82%

Hang Seng

19,055.50

+254.47

1.35%

Popovits Says Genomic Tests Individualize Cancer Care: Video

2011-04-06T00:06:46Z

Genomic's Popovits Interview About Cancer Tests

Play Video

April 5 (Bloomberg) -- Kim Popovits, chief executive officer of Genomic Health Inc., talks about the company's cancer tests. Genomic makes a gene test that helps identify which breast and colon cancer patients will benefit from chemotherapy. Popovits speaks with Cory Johnson and Emily Chang on Bloomberg Television's "Bloomberg West." (Source: Bloomberg)

Kim Popovits, chief executive officer of Genomic Health Inc., talks about the company's cancer tests.

Genomic makes a gene test that helps identify which breast and colon cancer patients will benefit from chemotherapy. Popovits speaks with Cory Johnson and Emily Chang on Bloomberg Television's "Bloomberg West." (Source: Bloomberg)

Running time 04:36

-0- Apr/06/2011 00:06 GMT